WBA

Walgreens Boots Alliance, Inc. [WBA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

WBA Stock Summary

Top 10 Correlated ETFs

WBA


Top 10 Correlated Stocks

WBA


In the News

05:29 29 Mar 2024 WBA

Walgreens Earnings, US Eco Data, SBF Sentencing | What We're Watching

Walgreens Earnings, US Eco Data, SBF Sentencing and much more coming tomorrow.

04:30 29 Mar 2024 WBA

Walgreens Earnings Are Thursday. Investors Want to See Changes.

The retail pharmacy chain reports results before the market open Thursday.

02:59 29 Mar 2024 WBA

Walgreens Boots to reveal new CEO strategy in trading update

Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A), the retail pharmacist, will likely showcase how its strategy is evolving under newly appointed CEO Tim Wentworth at its second quarter update on Thursday. Wentworth took charge of the group back in October 2023 but analysts are keen to learn about how he plans to deploy capital from sales over the long term and whether a ‘back to basics' plan will be launched.

10:15 29 Mar 2024 WBA

Countdown to Walgreens (WBA) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Walgreens (WBA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended February 2024.

02:00 29 Mar 2024 WBA

Walgreens, Carnival, GameStop and More to Watch This Week

The stock market will be closed on Good Friday. Plus, core PCE price index inflation data and earnings from GameStop, Carnival, and Walgreens Boots Alliance.

07:31 29 Mar 2024 WBA

Looking Ahead to Q1 Earnings

We are still a couple of weeks away from the March-quarter reporting cycle really getting underway with the big-bank results. But early results in recent days from companies for their February-ending fiscal quarters have given us some idea of what this coming earnings season will show.

06:50 29 Mar 2024 WBA

Walgreens Boots Alliance (WBA) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $20.58, denoting a -1.06% change from the preceding trading day.

06:16 29 Mar 2024 WBA

Jim Cramer's week ahead: New consumer data and earnings from Walgreens

CNBC's Jim Cramer on Friday guided investors through next week's most important happenings on Wall Street.

06:56 29 Mar 2024 WBA

Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $20.80, marking a -1.38% move from the previous day.

03:30 29 Mar 2024 WBA

Walgreens' Strategic Pivot

Walgreens Boots Alliance, Inc. faces challenges in its retail pharmacy business due to lower demand for COVID-19 testing and tight prescription drug payouts. The company is transitioning into a healthcare powerhouse, investing in primary care practices and offering in-home health services. Despite declining earnings and cash flow, there is potential for a rebound as Walgreens stock is undervalued and sales are growing in the healthcare division.

WBA Financial details

Company Rating
Buy
Market Cap
17.75B
Income
238M
Revenue
142.41B
Book val./share
31.97
Cash/share
0.91
Dividend
1.69
Dividend %
8.04%
Employees
330K
Optionable
Yes
Shortable
Yes
Earnings
28 Mar 2024
P/E
76.22
Forward P/E
8.71
PEG
-8.06
P/S
0.13
P/B
0.66
P/C
23.94
P/FCF
-34.27
Quick Ratio
0.26
Current Ratio
0.66
Debt / Equity
1.22
LT Debt / Equity
1.07
-
-
EPS (TTM)
0.27
EPS next Y
2.5
EPS next Q
0.9
EPS this Y
-171.12%
EPS next Y
816.87%
EPS next 5Y
1569.73%
EPS last 5Y
NAN%
Revenue last 5Y
0.32%
Revenue Q/Q
3.63%
EPS Q/Q
-63.05%
-
-
-
-
SMA20
-
SMA50
-12.5%
SMA100
-
Inst Own
45.74%
Inst Trans
0.79%
ROA
-
ROE
1%
ROC
-
Gross Margin
19%
Oper. Margin
-
Profit Margin
-
Payout
697%
Shs Outstand
862.38M
Shs Float
711.34M
-
-
-
-
Target Price
38.64
52W Range
19.68-36.58
52W High
-39.49%
52W Low
+14.66%
RSI
50
Rel Volume
2.05
Avg Volume
13.56M
Volume
27.78M
Perf Week
3.3%
Perf Month
-2.27%
Perf Quarter
-0.11%
Perf Half Y
2.09%
-
-
-
-
Beta
0.718
-
-
Volatility
0.41%, 0.46%
Prev Close
3.64%
Price
21.785
Change
5.65%

WBA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-08-31

Metric History 2019-08-312020-08-312021-08-312022-08-31 2023-08-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
148.53158.67153.23153.52161.21
Net income per share
4.320.521.545.02-3.57
Operating cash flow per share
6.076.246.424.512.62
Free cash flow per share
4.224.674.832.50.16
Cash per share
1.110.592.112.860.86
Book value per share
26.2124.0327.5533.9723.21
Tangible book value per share
-2.87-5.551.69-3.01-15.45
Share holders equity per share
26.2124.0327.5533.9723.21
Interest debt per share
19.0346.3739.6641.5139.54
Market cap
47.17B33.43B43.89B30.31B21.84B
Enterprise value
62.98B73.06B76.09B64.42B54.64B
P/E ratio
11.8573.3233.056.99-7.09
Price to sales ratio
0.340.240.330.230.16
POCF ratio
8.436.17.97.779.67
PFCF ratio
12.128.1310.5114154.87
P/B Ratio
1.951.581.841.031.09
PTB ratio
1.951.581.841.031.09
EV to sales
0.460.520.570.490.39
Enterprise value over EBITDA
8.6622.0813.9510.11-21.16
EV to operating cash flow
11.2613.3213.716.5224.2
EV to free cash flow
16.1817.7818.2229.76387.53
Earnings yield
0.080.010.030.14-0.14
Free cash flow yield
0.080.120.10.070.01
Debt to equity
0.71.91.41.211.67
Debt to assets
0.250.460.410.390.35
Net debt to EBITDA
2.1811.975.95.35-12.71
Current ratio
0.730.670.720.750.63
Interest coverage
7.12.053.8510.96-11.87
Income quality
1.4112.932.210.96-0.64
Dividend Yield
0.030.050.040.050.08
Payout ratio
0.413.831.220.38-0.54
Sales general and administrative to revenue
0.180.190.180.20.24
Research and developement to revenue
00000
Intangibles to total assets
0.240.30.280.370.43
Capex to operating cash flow
-0.3-0.25-0.25-0.44-0.94
Capex to revenue
-0.01-0.01-0.01-0.01-0.02
Capex to depreciation
-0.84-0.71-0.7-0.87-0.94
Stock based compensation to revenue
00000
Graham number
50.4816.7530.8561.9343.17
ROIC
0.10.010.030.05-0.06
Return on tangible assets
0.080.010.020.08-0.06
Graham Net
-35.09-63.05-54.71-57.04-68.66
Working capital
-7.07B-9B-6.24B-5.68B-9.03B
Tangible asset value
8.23B-4.89B1.47B-2.6B-13.33B
Net current asset value
-24.75B-47.97B-41.65B-42.81B-52.64B
Invested capital
0.71.91.41.211.67
Average receivables
6.9B7.18B6.4B5.34B5.2B
Average payables
13.95B14.4B12.8B11.2B11.95B
Average inventory
9.45B9.39B8.81B8.26B8.31B
Days sales outstanding
19.2718.6615.613.814.12
Days payables outstanding
49.0247.3238.9239.3441.17
Days of inventory on hand
31.930.9328.5129.1926.91
Receivables turnover
18.9419.5623.426.4525.85
Payables turnover
7.457.719.389.288.86
Inventory turnover
11.4411.812.812.513.57
ROE
0.160.020.060.15-0.15
Capex per share
-1.85-1.56-1.59-2.01-2.45

Quarterly Fundamentals Overview

Last date of statement is 2023-11-30 for Q1

Metric History 2022-11-302023-02-282023-05-312023-08-31 2023-11-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
38.6740.4241.0341.3542.53
Net income per share
-4.430.62-0.06-0.21-0.08
Operating cash flow per share
0.570.86-0.021.21-0.33
Free cash flow per share
-0.140.29-0.630.65-0.91
Cash per share
4.92.131.120.860.91
Book value per share
28.4734.1334.0223.3731.97
Tangible book value per share
-9.79-14.62-14.4-15.56-15.88
Share holders equity per share
28.4734.1334.0223.3731.97
Interest debt per share
41.2643.7342.4239.3339.21
Market cap
35.83B30.65B26.21B21.68B17.21B
Enterprise value
68.99B67.14B61.78B54.49B50.16B
P/E ratio
-2.3414.27-126.02-30.11-64.21
Price to sales ratio
1.070.880.740.610.47
POCF ratio
72.6741.08-1.31K20.87-61.24
PFCF ratio
-306.23123.58-48.139.07-21.87
P/B Ratio
1.461.040.891.080.62
PTB ratio
1.461.040.891.080.62
EV to sales
2.071.931.741.541.37
Enterprise value over EBITDA
-14.7951.33159.23141.53140.51
EV to operating cash flow
139.9490-3.09K52.44-178.51
EV to free cash flow
-589.67270.71-113.3698.18-63.74
Earnings yield
-0.110.020-0.010
Free cash flow yield
00.01-0.020.03-0.05
Debt to equity
1.441.281.241.671.22
Debt to assets
0.380.370.370.350.34
Net debt to EBITDA
-7.1127.991.6785.2192.31
Current ratio
0.70.630.630.630.66
Interest coverage
-56.415.3-1.21-2.91-0.39
Income quality
-0.131.370.42-51.01
Dividend Yield
0.010.010.020.020.02
Payout ratio
-0.110.77-7.98-2.31-6.19
Sales general and administrative to revenue
0000.180
Research and developement to revenue
0000.010
Intangibles to total assets
0.360.420.430.430.42
Capex to operating cash flow
-1.24-0.6726.25-0.471.8
Capex to revenue
-0.02-0.01-0.01-0.01-0.01
Capex to depreciation
-1.23-0.89-0.88-0.8-0.82
Stock based compensation to revenue
0.010000
Graham number
53.2621.866.7910.517.47
ROIC
-0.050.01000
Return on tangible assets
-0.060.01000
Graham Net
-64.4-69.98-69.11-69.15-69.61
Working capital
-8.51B-10.54B-9.63B-9.03B-8.77B
Tangible asset value
-8.46B-12.61B-12.43B-13.33B-13.71B
Net current asset value
-48.61B-53.19B-52.54B-52.64B-52.72B
Invested capital
1.441.281.241.671.22
Average receivables
4.94B5.29B5.79B5.61B5.68B
Average payables
11.72B12.45B12.37B12.33B13.11B
Average inventory
8.84B9.04B8.46B8.21B8.86B
Days sales outstanding
13.0814.7914.8513.6714.64
Days payables outstanding
41.4941.1737.5639.2840.86
Days of inventory on hand
31.7428.3425.4925.6728.42
Receivables turnover
6.886.086.066.586.15
Payables turnover
2.172.192.42.292.2
Inventory turnover
2.843.183.533.513.17
ROE
-0.160.020-0.010
Capex per share
-0.71-0.58-0.61-0.56-0.59

WBA Frequently Asked Questions

What is Walgreens Boots Alliance, Inc. stock symbol ?

Walgreens Boots Alliance, Inc. is a US stock , located in Deerfield of Il and trading under the symbol WBA

Is Walgreens Boots Alliance, Inc. buy or a sell ?

30 stock analysts have 30 predictions with a medium analyst target price of $41.53. The lowest prediction is $2 and the highest is $57

What is WBA stock prediction ?

With a median analyst target price of $20.5, 4 stock analysts have made 4 forecasts in last 90 days. $2 is the lowest and $37 is the greatest projection.

What is Walgreens Boots Alliance, Inc. stock quote today ?

Walgreens Boots Alliance, Inc. stock price is $21.785 today.

Is Walgreens Boots Alliance, Inc. stock public?

Yes, Walgreens Boots Alliance, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap